{"entity":{"type":"insider","cik":"0001856380","url":"/insider/0001856380","json_url":"/insider/0001856380.json","name":"Treace John T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":24,"first":"2021-04-29","last":"2026-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Treace John T.","source":"filing","n_filings":24,"first_seen":"2021-04-29","last_seen":"2026-06-12"}],"transactions":[{"id":9255218,"accession":"0001193125-26-268606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-268606","line_url":"/filing/0001193125-26-268606#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9891.0,"shares_display":"9,891","price_per_share":4.0423,"price_display":"4.04","price_state":"stated","total_value":39982.3893,"total_display":"39,982.39","total_whole":"39,982","shares_owned_after":7348439.0,"shares_owned_after_display":"7,348,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-12","scope":"insider"},{"id":5930416,"accession":"0001193125-26-267800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-267800","line_url":"/filing/0001193125-26-267800#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22887.0,"shares_display":"22,887","price_per_share":4.0434,"price_display":"4.04","price_state":"stated","total_value":92541.2958,"total_display":"92,541.30","total_whole":"92,541","shares_owned_after":7376150.0,"shares_owned_after_display":"7,376,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-11","scope":"insider"},{"id":9255219,"accession":"0001193125-26-268606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-268606","line_url":"/filing/0001193125-26-268606#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14715.0,"shares_display":"14,715","price_per_share":4.024,"price_display":"4.02","price_state":"stated","total_value":59213.16,"total_display":"59,213.16","total_whole":"59,213","shares_owned_after":7338548.0,"shares_owned_after_display":"7,338,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-12","scope":"insider"},{"id":5930414,"accession":"0001193125-26-267800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-267800","line_url":"/filing/0001193125-26-267800#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29430.0,"shares_display":"29,430","price_per_share":4.024,"price_display":"4.02","price_state":"stated","total_value":118426.32,"total_display":"118,426.32","total_whole":"118,426","shares_owned_after":7353263.0,"shares_owned_after_display":"7,353,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-11","scope":"insider"},{"id":5944139,"accession":"0001193125-26-251587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-251587","line_url":"/filing/0001193125-26-251587#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.5583,"price_display":"3.56","price_state":"stated","total_value":177915.0,"total_display":"177,915.00","total_whole":"177,915","shares_owned_after":7323833.0,"shares_owned_after_display":"7,323,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider"},{"id":5749642,"accession":"0001193125-26-245341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-245341","line_url":"/filing/0001193125-26-245341#line-3","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61202.0,"shares_display":"61,202","price_per_share":3.0199,"price_display":"3.02","price_state":"stated","total_value":184823.9198,"total_display":"184,823.92","total_whole":"184,824","shares_owned_after":7273833.0,"shares_owned_after_display":"7,273,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-05-28","scope":"insider"},{"id":5749641,"accession":"0001193125-26-245341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-245341","line_url":"/filing/0001193125-26-245341#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49810.0,"shares_display":"49,810","price_per_share":2.8747,"price_display":"2.87","price_state":"stated","total_value":143188.807,"total_display":"143,188.81","total_whole":"143,189","shares_owned_after":7212631.0,"shares_owned_after_display":"7,212,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-27","filed_date":"2026-05-28","scope":"insider"},{"id":5749640,"accession":"0001193125-26-245341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-245341","line_url":"/filing/0001193125-26-245341#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4508.0,"shares_display":"4,508","price_per_share":2.7897,"price_display":"2.79","price_state":"stated","total_value":12575.9676,"total_display":"12,575.97","total_whole":"12,576","shares_owned_after":7162821.0,"shares_owned_after_display":"7,162,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-28","scope":"insider"},{"id":5894462,"accession":"0001193125-26-224391","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-224391","line_url":"/filing/0001193125-26-224391#line-3","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61750.0,"shares_display":"61,750","price_per_share":2.6153,"price_display":"2.62","price_state":"stated","total_value":161494.775,"total_display":"161,494.78","total_whole":"161,495","shares_owned_after":7158313.0,"shares_owned_after_display":"7,158,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-14","scope":"insider"},{"id":5894460,"accession":"0001193125-26-224391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-224391","line_url":"/filing/0001193125-26-224391#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49013.0,"shares_display":"49,013","price_per_share":2.4592,"price_display":"2.46","price_state":"stated","total_value":120532.7696,"total_display":"120,532.77","total_whole":"120,533","shares_owned_after":7096563.0,"shares_owned_after_display":"7,096,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-14","scope":"insider"},{"id":5894458,"accession":"0001193125-26-224391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-224391","line_url":"/filing/0001193125-26-224391#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43000.0,"shares_display":"43,000","price_per_share":2.1739,"price_display":"2.17","price_state":"stated","total_value":93477.7,"total_display":"93,477.70","total_whole":"93,478","shares_owned_after":7047550.0,"shares_owned_after_display":"7,047,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-14","scope":"insider"},{"id":4616057,"accession":"0000950170-25-032626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-032626","line_url":"/filing/0000950170-25-032626#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":8.7344,"price_display":"8.73","price_state":"stated","total_value":524064.0,"total_display":"524,064.00","total_whole":"524,064","shares_owned_after":6796190.0,"shares_owned_after_display":"6,796,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":2986720,"accession":"0000950170-24-107401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-107401","line_url":"/filing/0000950170-24-107401#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":5.3126,"price_display":"5.31","price_state":"stated","total_value":265630.0,"total_display":"265,630.00","total_whole":"265,630","shares_owned_after":6523095.0,"shares_owned_after_display":"6,523,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2082624,"accession":"0000950170-24-097694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-097694","line_url":"/filing/0000950170-24-097694#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85000.0,"shares_display":"85,000","price_per_share":6.0037,"price_display":"6.00","price_state":"stated","total_value":510314.5,"total_display":"510,314.50","total_whole":"510,315","shares_owned_after":6473095.0,"shares_owned_after_display":"6,473,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2895670,"accession":"0000950170-24-072078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-072078","line_url":"/filing/0000950170-24-072078#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":5.88,"price_display":"5.88","price_state":"stated","total_value":264600.0,"total_display":"264,600.00","total_whole":"264,600","shares_owned_after":6388095.0,"shares_owned_after_display":"6,388,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider"},{"id":3073853,"accession":"0000950170-24-062435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-062435","line_url":"/filing/0000950170-24-062435#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":5.5617,"price_display":"5.56","price_state":"stated","total_value":556170.0,"total_display":"556,170.00","total_whole":"556,170","shares_owned_after":6343095.0,"shares_owned_after_display":"6,343,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"},{"id":3020520,"accession":"0000950170-24-059854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-059854","line_url":"/filing/0000950170-24-059854#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":5.1187,"price_display":"5.12","price_state":"stated","total_value":767805.0,"total_display":"767,805.00","total_whole":"767,805","shares_owned_after":6243095.0,"shares_owned_after_display":"6,243,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-14","scope":"insider"},{"id":2636601,"accession":"0000950170-24-058878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-058878","line_url":"/filing/0000950170-24-058878#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":4.5566,"price_display":"4.56","price_state":"stated","total_value":683490.0,"total_display":"683,490.00","total_whole":"683,490","shares_owned_after":6093095.0,"shares_owned_after_display":"6,093,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-13","scope":"insider"},{"id":2636595,"accession":"0000950170-24-058878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-058878","line_url":"/filing/0000950170-24-058878#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":4.5792,"price_display":"4.58","price_state":"stated","total_value":686880.0,"total_display":"686,880.00","total_whole":"686,880","shares_owned_after":5943095.0,"shares_owned_after_display":"5,943,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-13","scope":"insider"},{"id":8392552,"accession":"0001209191-23-018046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018046","line_url":"/filing/0001209191-23-018046#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2075.0,"shares_display":"2,075","price_per_share":24.41,"price_display":"24.41","price_state":"stated","total_value":50650.75,"total_display":"50,650.75","total_whole":"50,651","shares_owned_after":5539380.0,"shares_owned_after_display":"5,539,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-09","filed_date":"2023-03-10","scope":"insider"},{"id":6894838,"accession":"0001209191-22-058266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058266","line_url":"/filing/0001209191-22-058266#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":21.827,"price_display":"21.83","price_state":"stated","total_value":327405.0,"total_display":"327,405.00","total_whole":"327,405","shares_owned_after":5541455.0,"shares_owned_after_display":"5,541,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-21","scope":"insider"},{"id":6730579,"accession":"0001209191-22-057654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057654","line_url":"/filing/0001209191-22-057654#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":21.6714,"price_display":"21.67","price_state":"stated","total_value":216714.0,"total_display":"216,714.00","total_whole":"216,714","shares_owned_after":5526455.0,"shares_owned_after_display":"5,526,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-17","scope":"insider"},{"id":6987340,"accession":"0001209191-22-048290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-048290","line_url":"/filing/0001209191-22-048290#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":19.8031,"price_display":"19.80","price_state":"stated","total_value":198031.0,"total_display":"198,031.00","total_whole":"198,031","shares_owned_after":5516455.0,"shares_owned_after_display":"5,516,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-01","scope":"insider"},{"id":6574240,"accession":"0001209191-22-047786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047786","line_url":"/filing/0001209191-22-047786#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21491.0,"shares_display":"21,491","price_per_share":20.9549,"price_display":"20.95","price_state":"stated","total_value":450341.7559,"total_display":"450,341.76","total_whole":"450,342","shares_owned_after":5506455.0,"shares_owned_after_display":"5,506,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-08-29","scope":"insider"},{"id":6149509,"accession":"0001209191-22-047407","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-047407","line_url":"/filing/0001209191-22-047407#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":509.0,"shares_display":"509","price_per_share":18.9232,"price_display":"18.92","price_state":"stated","total_value":9631.9088,"total_display":"9,631.91","total_whole":"9,632","shares_owned_after":5484964.0,"shares_owned_after_display":"5,484,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-24","scope":"insider"},{"id":6149506,"accession":"0001209191-22-047407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047407","line_url":"/filing/0001209191-22-047407#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Offer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Offer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28000.0,"shares_display":"28,000","price_per_share":18.7187,"price_display":"18.72","price_state":"stated","total_value":524123.6,"total_display":"524,123.60","total_whole":"524,124","shares_owned_after":5484455.0,"shares_owned_after_display":"5,484,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-24","scope":"insider"},{"id":5122158,"accession":"0001567619-21-022717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-022717","line_url":"/filing/0001567619-21-022717#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3075.0,"shares_display":"3,075","price_per_share":17.013,"price_display":"17.01","price_state":"stated","total_value":52314.975,"total_display":"52,314.98","total_whole":"52,315","shares_owned_after":5422580.0,"shares_owned_after_display":"5,422,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2021-12-30","scope":"insider"},{"id":5122151,"accession":"0001567619-21-022717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022717","line_url":"/filing/0001567619-21-022717#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19760.0,"shares_display":"19,760","price_per_share":16.9941,"price_display":"16.99","price_state":"stated","total_value":335803.416,"total_display":"335,803.42","total_whole":"335,803","shares_owned_after":5425655.0,"shares_owned_after_display":"5,425,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-30","scope":"insider"},{"id":4277474,"accession":"0001567619-21-022542","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-022542","line_url":"/filing/0001567619-21-022542#line-3","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17165.0,"shares_display":"17,165","price_per_share":17.4409,"price_display":"17.44","price_state":"stated","total_value":299373.0485,"total_display":"299,373.05","total_whole":"299,373","shares_owned_after":5445415.0,"shares_owned_after_display":"5,445,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-27","scope":"insider"},{"id":4277471,"accession":"0001567619-21-022542","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-022542","line_url":"/filing/0001567619-21-022542#line-2","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22795.0,"shares_display":"22,795","price_per_share":16.9573,"price_display":"16.96","price_state":"stated","total_value":386541.6535,"total_display":"386,541.65","total_whole":"386,542","shares_owned_after":5462580.0,"shares_owned_after_display":"5,462,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-27","scope":"insider"},{"id":4277467,"accession":"0001567619-21-022542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022542","line_url":"/filing/0001567619-21-022542#line-1","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41710.0,"shares_display":"41,710","price_per_share":16.2876,"price_display":"16.29","price_state":"stated","total_value":679355.796,"total_display":"679,355.80","total_whole":"679,356","shares_owned_after":5485375.0,"shares_owned_after_display":"5,485,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-27","scope":"insider"},{"id":5009304,"accession":"0001567619-21-022460","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-022460","line_url":"/filing/0001567619-21-022460","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37584.0,"shares_display":"37,584","price_per_share":16.11173290229885,"price_display":"16.11","price_state":"stated","total_value":605543.3694,"total_display":"605,543.37","total_whole":"605,543","shares_owned_after":5530622.0,"shares_owned_after_display":"5,530,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-22","scope":"insider","n_lines":2},{"id":5009294,"accession":"0001567619-21-022460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-022460","line_url":"/filing/0001567619-21-022460","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22911.0,"shares_display":"22,911","price_per_share":15.752114233337698,"price_display":"15.75","price_state":"stated","total_value":360896.6892,"total_display":"360,896.69","total_whole":"360,897","shares_owned_after":5565269.0,"shares_owned_after_display":"5,565,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-22","scope":"insider","n_lines":2},{"id":4327451,"accession":"0001567619-21-021184","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-21-021184","line_url":"/filing/0001567619-21-021184","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56000.0,"shares_display":"56,000","price_per_share":17.8443637875,"price_display":"17.84","price_state":"stated","total_value":999284.3721,"total_display":"999,284.37","total_whole":"999,284","shares_owned_after":5587580.0,"shares_owned_after_display":"5,587,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":4327441,"accession":"0001567619-21-021184","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-021184","line_url":"/filing/0001567619-21-021184","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56000.0,"shares_display":"56,000","price_per_share":17.405127544642855,"price_display":"17.41","price_state":"stated","total_value":974687.1425,"total_display":"974,687.14","total_whole":"974,687","shares_owned_after":5646305.0,"shares_owned_after_display":"5,646,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":4327434,"accession":"0001567619-21-021184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-021184","line_url":"/filing/0001567619-21-021184","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53000.0,"shares_display":"53,000","price_per_share":18.34938528301887,"price_display":"18.35","price_state":"stated","total_value":972517.42,"total_display":"972,517.42","total_whole":"972,517","shares_owned_after":5700226.0,"shares_owned_after_display":"5,700,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":4830892,"accession":"0001567619-21-018627","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001567619-21-018627","line_url":"/filing/0001567619-21-018627","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58089.0,"shares_display":"58,089","price_per_share":20.743694654753913,"price_display":"20.74","price_state":"stated","total_value":1204980.4788,"total_display":"1,204,980.48","total_whole":"1,204,980","shares_owned_after":5753135.0,"shares_owned_after_display":"5,753,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-22","scope":"insider","n_lines":2},{"id":4830880,"accession":"0001567619-21-018627","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001567619-21-018627","line_url":"/filing/0001567619-21-018627","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76084.0,"shares_display":"76,084","price_per_share":20.781277782450974,"price_display":"20.78","price_state":"stated","total_value":1581122.7388,"total_display":"1,581,122.74","total_whole":"1,581,123","shares_owned_after":5852428.0,"shares_owned_after_display":"5,852,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-22","scope":"insider","n_lines":6},{"id":4830841,"accession":"0001567619-21-018627","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-018627","line_url":"/filing/0001567619-21-018627#line-3","is_derivative":false,"issuer_cik":"0001630627","issuer_name":"TREACE MEDICAL CONCEPTS, INC.","issuer_ticker":"TMCI","issuer_name_source":null,"issuer_url":"/issuer/0001630627","owner_cik":"0001856380","owner_name":"Treace John T.","owner_display_name":"Treace John T.","owner_url":"/insider/0001856380","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22612.0,"shares_display":"22,612","price_per_share":24.7891,"price_display":"24.79","price_state":"stated","total_value":560531.1292,"total_display":"560,531.13","total_whole":"560,531","shares_owned_after":5894968.0,"shares_owned_after_display":"5,894,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-20","filed_date":"2021-10-22","scope":"insider"}],"collapsed":true,"next_cursor":"2021-10-20|4830841","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":25,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001630627","name":"TREACE MEDICAL CONCEPTS, INC.","url":"/issuer/0001630627","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":24,"first_seen":"2021-04-29","last_seen":"2026-06-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001856380","retrieved_at":"2026-08-24T20:44:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}